For women, the guidance does not mandate routine testosterone blood tests, but it calls for screening for fatigue and disrupted menstrual cycles that can be associated ​with hormonal dysregulation ​and conditions called ⁠low-energy availability and relative energy deficiency in sport. The document lays out guidelines for when it ​is appropriate to prescribe off-label testosterone in women, ​namely for ⁠postmenopausal women with unusually low sexual desire.